Try our beta test site
51689 studies found for:    Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Photodynamic Therapy Incubation Times for Actinic Keratosis
Condition: Actinic Keratoses
Interventions: Drug: ALA (5-aminolevulinic acid);   Device: Blue light therapy
2 Not yet recruiting Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sotagliflozin (SAR439954);   Drug: placebo;   Drug: Metformin;   Drug: Sulfonylurea
3 Not yet recruiting Vitamin D and Bone Homeostasis in Ortho Polytrauma Patients
Conditions: Vitamin D Deficiency;   Polytrauma;   Orthopedic Disorder
Interventions: Drug: Ergocalciferol 8000 IU/ML Oral Liquid [DRISDOL];   Drug: Propylene Glycol
4 Not yet recruiting A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Condition: Heart Failure With Preserved Ejection Fraction
Interventions: Drug: sacubitril/valsartan;   Drug: Enalapril;   Drug: Valsartan;   Drug: Placebo to match sacubitril/valsartan;   Drug: Placebo to match enalapril;   Drug: Placebo to match valsartan
5 Recruiting Turmeric and Curcumin on Sebum Production
Condition: Inflammation; Skin
Interventions: Dietary Supplement: Turmeric tablets;   Dietary Supplement: Curcumin and Bioperine tablets;   Dietary Supplement: Placebo Tablets
6 Not yet recruiting A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)
Condition: Small Cell Lung Cancer (SCLC)
Interventions: Biological: Pembrolizumab;   Drug: Normal saline solution;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Etoposide
7 Not yet recruiting Cognitive Dysfunction in MS: Using Altered Brain Oscillation to Link Molecular Mechanisms With Clinical Outcomes
Condition: Pediatric Multiple Sclerosis
Intervention:
8 Not yet recruiting Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia
Condition: Hyperalgesia
Interventions: Drug: Remifentanil;   Drug: Remifentanil+ Placebo;   Drug: Remifentanil +ultra-low dose naloxone
9 Not yet recruiting Does the Cerebroplacental Ratio (CPR) Predict Adverse Outcomes in Low Risk Pregnancies?
Condition: Cerebroplacental Ratio
Intervention:
10 Recruiting Post-prandial Glucose Response From Phytochemical Rich Potato Products
Conditions: Glycemic Response;   Appetitive Behavior
Interventions: Other: Skin Off French Fry;   Other: Skin On French Fry;   Other: Hash brown;   Other: Carbohydrate control
11 Not yet recruiting Prognostic Factors in Malignant GI Bleeding Treated With Hemostatic Powder
Condition: Death
Intervention: Device: Hemostatic powder
12 Not yet recruiting A Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Participants
Condition: Healthy
Intervention: Drug: Erdafitinib
13 Available Expanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene Fusions
Condition: Cancers With NTRK, ROS1, or ALK Gene Fusions
Intervention: Drug: Entrectinib
14 Not yet recruiting Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS
Conditions: Leukemia;   Leukemia, Myeloid;   Leukemia, Myeloid, Acute;   Myelodysplastic Syndromes;   Preleukemia;   Bone Marrow Diseases;   Hematologic Diseases
Interventions: Drug: Decitabine;   Drug: PDR001;   Drug: MBG453
15 Not yet recruiting Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues
Condition: Cluster Headache
Interventions: Drug: Botulinum Toxin Type A 25 IU;   Drug: Botulinum Toxin Type A 12.5 IU
16 Recruiting Olanzapine for Acute Headaches
Condition: Headache
Interventions: Drug: Standard of Care as per attending physician;   Drug: 5mg rapidly dissolving olanzapine
17 Not yet recruiting Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Secukinumab 150 mg s.c.;   Drug: Secukinumab 300 mg s.c.;   Drug: Placebo
18 Not yet recruiting Promoting Asthma Guidelines and Management Through Technology-Based Intervention and Care Coordination
Condition: Asthma Childhood
Intervention: Behavioral: PRAGMATIC
19 Recruiting Effectiveness of Trephination With Platelet Rich Plasma or Placebo in a Primary Meniscal Tear Treatment
Condition: Meniscus Lesion
Interventions: Biological: trephination with placebo;   Biological: trephination with platelet rich plasma
20 Not yet recruiting Graded Exposure in Patients With Painful Diabetic Neuropathy
Conditions: Painful Diabetic Neuropathy;   Diabetic Neuropathies, Painful;   Neuralgia, Diabetic
Intervention: Behavioral: Graded Exposure

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.